HOSPITAL UNIVERSITARIO RUBER
Departamento
University of Parma
Parma, ItaliaPublicaciones en colaboración con investigadores/as de University of Parma (1)
2023
-
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 2, pp. 198-205